{"task_id": "cb0283dd0f5c1def", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 22/464)", "text": " decid\ning on possible hospitalization\n6\nPneumonia\n\n--- Page 28 ---\nINVESTIGATIONS (CONT\u2019D)\nSPECIAL\n\u0002\nBRONCHOSCOPY\n\u0002\nNASOPHARYNGEAL SWAB\nif suspect viral infec\ntion, check for influenza A/B, parainfluenza,\nhuman metapneumovirus, RSV, adenovirus\n\u0002\nMYCOPLASMA IGM\n\u0002\nURINE FOR LEGIONELLA ANTIGEN\nDIAGNOSTIC AND PROGNOSTIC ISSUES\nPNEUMONIA SEVERITY OF ILLNESS (PSI) SCORE\n\u0002\nSCORING\nage, female ( 10), nursing home (+10),\ncancer (+30), liver disease (+20), heart failure\n(+10), CVA (+10), renal failure (+10), altered men\ntal status (+20), RR >30 (+20), SBP <90 mmHg\n(+20), temp >408C [>1048F] (+15), HR >125\n(+10), pH <7.35 (+30), BUN >10.7 mmol/L\n[>30 mg/dL] +20, Na <130 mmol/L (+20), glucose\n>13.9 mmol/L [>250 mg/dL] +10, hematocrit\n<30% (+10), PaO2 <60 mmHg or O2 saturation\n<90% on room air (+10), pleural effusion (+10)\n\u0002\nUTILITY\noriginally developed as a prognostic tool.\nConsider admission if PSI score >90. Clinical judg\nment more important than PSI in determining\nadmission\nNEJM 2002 347:25\nMANAGEMENT\nACUTE\nABC, O2, IV, consider salbutamol 2.5 mg\nNEB q6h + q1h PRN\nANTIBIOTICS\n\u0002\nCOMMUNITY-ACQUIRED PNEUMONIA\nsee treatment\nissues for an approach to selecting the appropriate\nregimen (remember to adjust for renal function)\n\u0002\nTETRACYCLINE\ndoxycycline 100 mg PO BID \u000310\ndays\n\u0002\nMACROLIDES\nazithromycin 500 mg PO first day,\nthen 250 mg PO daily \u00034 days; clarithromycin\n250 500 mg PO BID \u000310 days\n\u0002\nFLUOROQUINOLONES\nlevofloxacin 500 mg PO\ndaily \u000310 days (or 750 mg \u00035 days), moxifloxacin\n400 mg PO daily \u000310 days; avoid if exposed to\nfluoroquinolone within last 3 6 months\n\u0002 b-LACTAMS\namoxicillin 1 g PO TID, amoxicil\nlin clavulanate 2 g PO BID, cefuroxime 750 mg\nIV q8h or 500 mg PO BID, cefotaxime 1 g IV q8h\n\u0002\nANAEROBIC COVERAGE\nif suspect aspiration, add\nclindamycin 150 450 mg PO q6h or 600 900 mg\nIV q8h or metronidazole 500 mg PO/IV BID/TID\n\u0002\nNOSOCOMIAL PNEUMONIA\nsee treatment issues for\nan approach to selecting the appropriate regimen\n\u0002\nANTI-PSEUDOMONAL\nceftazidime, cefepime, mer\nopenem, ciprofloxacin, aminoglycosides, pipera\ncillin tazobactam (do not use same class of agent\nwhen double covering for pseudomonas)\nMANAGEMENT (CONT\u2019D)\n\u0002\nFURTHER GRAM-NEGATIVE COVERAGE\nciprofloxa\ncin 500 mg PO BID, gentamicin 6 mg/kg IV q24h,\ntobramycin 6 mg/kg IV q24h (follow levels to\nadjust dosing)\n\u0002\nANAEROBIC\nCOVERAGE\nif\nsuspect aspiration,\nreplace\ngentamicin\nwith\nclindamycin\n150 450 mg PO q6h or 600 900 mg IV q8h or\nadd metronidazole 500 mg PO BID\n\u0002\nANTIBIOTIC COURSE\n10 14 days for most, 21\ndays for Pseudomonas, Staphylococcus aureus,\nand Acinetobacter\n\u0002\nASPIRATION PNEUMONIA\nclindamycin 600 mg IV\nBID, switch to 300 mg PO QID when stable. May\nadd cefotaxime for Gram positive and Gram nega\ntive coverage\n\u0002\nTUBERCULOSIS PNEUMONIA\nsee p. 250\n\u0002 PNEUMOCYSTIS JIROVECI PNEUMONIA\nsee p. 259\nNON PHARMACOLOGIC TREATMENTS\n\u0002\nVACCINATIONS\ninfluenza vaccine annually and\npneumococcal vaccine booster at 5 years\n\u0002\nCHEST PHYSIOTHERAPY\nTREATMENT ISSUES\nIMPORTANT NOTE\navoid using the same antibiotic\nclass if given within 3 months\nOUTPATIENT ANTIBIOTICS CHOICE\n\u0002\nPREVIOUSLY\nHEALTHY\nmacrolide\n(azithromycin,\nclarithromycin, or doxycycline). Other antibiotic\nchoices include fluoroquinolone, macrolide plus\namoxicillin \u0007 clavulanate\n\u0002\nCOMORBIDITIES (COPD, diabetes, renal failure, HF,\nmalignancy)\nmacrolide or fluoroquinolone\n\u0002\nSUSPECTED ASPIRATION WITH INFECTION\namoxi\ncillin clavulanate or clindamycin\n\u0002\nINFLUENZA\nWITH\nBACTERIAL\nSUPERINFECTION\nb\nlactam or fluoroquinolone\nINPATIENT\nANTIBIOTIC\nCHOICE\nsecond third\ngeneration b lactam plus macrolide or respiratory\nfluoroquinolone\nICU ANTIBIOTICS CHOICE\n\u0002 PSEUDOMONAS UNLIKELY\nmacrolide plus b lactam\nor fluoroquinolone plus b lactam\n\u0002 PSEUDOMONAS UNLIKELY BUT b-LACTAM ALLERGY\nfluoroquinolone with or without clindamycin\n\u0002 PSEUDOMONAS\nLIKELY\ndouble\ncoverage\nwith\nagents that are effective against Pseudomonas\n(different classes)\n\u0002 PSEUDOMONAS\nLIKELY\nBUT b-LACTAM\nALLERGY\naztreonam plus levofloxacin or aztreonam plus\nmoxifloxacin, with or without aminoglycoside\nNURSING HOME ANTIBIOTICS CHOICE\n\u0002\nTREATMENT IN NURSING HOME\nfluoroquinolone or\nmacrolide plus amoxicillin clavulanate\n\u0002\nIN HOSPITAL\nsame as inpatient\nPneumonia\n7", "text_length": 4166, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 22/464)", "type": "chunk", "chunk_index": 21, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.261913", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.262855", "status": "complete", "chunks_added": 3}